UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000006547 |
|---|---|
| Receipt number | R000007757 |
| Scientific Title | Phase II study of q3w nab-paclitaxel in combination with q3w trastuzumab for HER2 positive metastatic breast cancer. |
| Date of disclosure of the study information | 2011/10/16 |
| Last modified on | 2019/10/17 08:09:04 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2011/10/16 10:22:28 | ||
| 2 | Update | 2019/10/17 08:09:04 | Recruitment status Date of IRB Last follow-up date |
